Camptosar 20 mg/mL

Camptosar 20 mg/mL is an injectable solution containing irinotecan hydrochloride, used in cancer treatment. This single-dose vial is designed for intravenous administration.

Camptosar 20 mg/mL is primarily used in the treatment of certain types of cancer. It is often prescribed for advanced colorectal cancer, either alone or in combination with other chemotherapy drugs. The medication works by interfering with the growth and spread of cancer cells. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Common effects of Camptosar 20 mg/mL may include nausea, vomiting, diarrhea, and fatigue. Some patients may experience hair loss or changes in blood cell counts. These effects can vary in severity and duration. It is important to discuss any persistent or severe side effects with a healthcare professional.

Camptosar 20 mg/mL should be handled with care, as it is a potent medication. It is essential to follow proper storage and disposal guidelines to ensure safety. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider, as this medication may cause harm to a developing fetus. Always use this medication under the supervision of a qualified healthcare professional.

Camptosar 20 mg/mL may interact with other medications, including those that affect the liver or blood cell production. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with this medication, so it is advisable to follow a healthcare provider's guidance on diet and lifestyle during treatment.